Composition | durvalumab |
Packaging Type | vial |
Dose/Strength | 500mg |
Dosage Form | 500mg |
Form of Medicine | injection |
Brand | Durvalumab |
Imfinzi 500mg available with us.
Durvalumab is an FDA-approved immunotherapy for cancer, developed by Medimmune. It is a human immunoglobulin G1 kappa monoclonal antibody that blocks the interaction of programmed cell death ligand 1 with the PD-1.
Composition | durvalumab |
Packaging Type | vial |
Dose/Strength | 500mg |
Dosage Form | 500mg |
Form of Medicine | injection |
Brand | Durvalumab |
Imfinzi 500mg available with us.
Durvalumab is an FDA-approved immunotherapy for cancer, developed by Medimmune. It is a human immunoglobulin G1 kappa monoclonal antibody that blocks the interaction of programmed cell death ligand 1 with the PD-1.